Cardiologist referrals improve cholesterol levels in prostate cancer patients, but may not be necessary for all
· Medical Xpressedited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A large international, first-of-its-kind study led by Hamilton researchers found that routine referrals to an internist or cardiologist improved cholesterol levels but did not lead to fewer heart attacks, strokes, heart failure or cardiovascular deaths.
The findings were published simultaneously in JAMA Internal Medicine and presented at the European Society of Cardiology Congress on Aug. 30, 2026, by Darryl Leong, the study's principal investigator and a senior scientist at the Population Health Research Institute (PHRI), a joint institute of Hamilton Health Sciences and McMaster University.
Researchers aimed to explore whether involving a cardiologist or internist in the care of prostate cancer patients could improve management of cardiovascular risk factors and reduce serious heart-related complications.
Better risk control, mixed outcomes
After nearly six years of follow-up, participants referred to a cardiologist or internist in addition to usual prostate cancer care were significantly more likely to receive statin therapy (63% versus 40%) and blood pressure medication (56% versus 49%) than those receiving usual care alone. Over time, the referred group also had significantly lower cholesterol levels.
Despite these improvements, there was no significant difference between the groups in cardiovascular death, heart attack, stroke or heart failure during follow-up. Researchers noted that fewer participants experienced these complications than expected, making it harder to determine whether the referral strategy affected those outcomes.
"I was surprised that we didn't see a reduction in heart attacks, strokes, heart failure or cardiovascular death in the group referred to a specialist," said Leong, director of the McMaster University and HHS Cardio-Oncology Program, HHS cardiologist, and an associate professor with McMaster's Department of Medicine.
"However, looking closely at the data, there is a signal suggesting a reduction in heart attacks, which is consistent with the cholesterol-lowering effect we observed. That finding needs to be confirmed through further research."
Heart risks during hormone treatment
Androgen deprivation therapy (ADT), a common prostate cancer treatment, can increase the risk of diabetes, high blood pressure and heart disease. While clinical guidelines recommend monitoring and managing these risks, there has been little evidence on whether adding cardiovascular care to prostate cancer treatment would improve outcomes for patients.
"When someone is diagnosed with prostate cancer, the focus is often on the cancer. But heart health is important too, especially for patients receiving hormone therapy," said Leong. "We wanted to understand whether involving a cardiovascular specialist could help patients manage risk factors like cholesterol, blood pressure and diabetes, adopt healthier habits and lifestyles, and eventually improve their health."
How the trial was set up
The RADICAL PC 2 trial enrolled 2,501 participants from eight countries (Canada, Brazil, Singapore, Colombia, India, Australia, Israel and the United States) from 2015 to 2025. Participants were men with newly diagnosed prostate cancer or those who were beginning ADT for the first time.
The participants in this study were randomly assigned to one of two groups: The first group received their usual cancer care, and the second received usual care in addition to a referral to an internist or cardiologist, who was asked to provide:
- Personalized advice on healthy eating and exercise
- Guidance on quitting smoking
- A cholesterol-lowering medication (statin), regardless of existing cholesterol levels
- Blood pressure medication, if blood pressure was above target (130 mmHg)
Who may benefit most
While routine referral to a cardiovascular specialist may not be necessary for every prostate cancer patient, some men are more likely to benefit than others.
An accompanying study published simultaneously in JACC CardioOncology identified patients most likely to benefit from referral to a cardiovascular specialist. Men with blood pressure above 130/80, diabetes or cholesterol above 4 mmol/L were found to be most likely to benefit.
Researchers say the findings highlight the importance of ensuring cardiovascular risk factors are addressed as part of routine prostate cancer care.
"Cardiovascular risk factors like high cholesterol, high blood pressure, diabetes and smoking are often poorly addressed in patients with prostate cancer," added Leong.
"I hope these findings raise awareness of heart disease risk among both prostate cancer patients and their health care providers and help doctors make smarter decisions about how we care for these patients so that conditions like high cholesterol, high blood pressure and diabetes don't get lost in the focus on cancer treatment."
Leong encourages prostate cancer patients to ask questions about their heart health.
"If you have prostate cancer, ask your health care provider what your blood pressure, cholesterol and blood sugar levels are and whether they need to be better controlled. Taking care of your heart health is an important part of your cancer care."
Publication details
JAMA Internal Medicine (2026)
JACC CardioOncology (2026)
Journal information: JAMA Internal Medicine
Key medical concepts
Prostate CancerAntiandrogen Therapy
Clinical categories
OncologyCardiologyCommon illnesses & PreventionMen's healthHealthy living Provided by McMaster University Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Cardiologist referrals improve cholesterol levels in prostate cancer patients, but may not be necessary for all (2026, August 30) retrieved 30 August 2026 from https://medicalxpress.com/news/2026-08-cardiologist-referrals-cholesterol-prostate-cancer.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.